Single-cell Omics Market Size

Single-cell Omics Market size is poised to cross USD 30 Billion by the end of 2035, growing at a CAGR of approximately 22% during the forecast period, i.e., 2023 – 2035. In the year 2022, the industry size of single-cell omics was nearly USD 3 Billion.  Advancement in the studies of RNA sequencing is a major driver for the growth of the single-cell omics market. Since RNA sequencing provides a comprehensive snapshot of gene expression profiles in cells. By studying gene expression patterns at the single-cell level, researchers can identify and characterize distinct cell populations and subtypes within a tissue or organism. This has opened up new avenues for single-cell omics development.

Besides this, the rising investment in cell sequencing is also expected to augment the single-cell omics market growth. The National Institutes of Health (NIH) recently granted Texas A&M University System a USD 1.19 million grant for a collaboration between multiple disciplines to explore the deep links between genomes, nutrition, and health. The investment in cell sequencing is driven by the growing demand for single-cell omics research. Moreover, higher investment enables the development of innovative approaches for disease diagnosis, and therapeutic development.